AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
In this episode, recorded in-person at the recent reMind conference, Joe interviews Kaci Hohmann and Dave Kopilak: business attorneys at Emerge Law Group and co-chairs of Emerge’s psychedelics practice group. Hohmann also serves as Chair of the Oregon State Bar’s Cannabis and Psychedelics Law Section.
They were both drafters of Oregon Measure 109 (with Kopilak as the primary drafter), so this episode goes deep into the details, legalities, and possibilities behind Measure 109. What licenses are involved? What does a business heading to Oregon need to prepare for? What do they think the feds will do and how does that relate to cannabis’ Cole Memorandum? What is tax code 280E and how can its effects be minimized? What do they see the future looking like?
They discuss what they do for clients at Emerge Law Group; the differences between the cannabis and psychedelics industries; why service centers are likely more important than the products; and how the psilocybin service center experience is more like a relationship with clients than anything in the cannabis world, which makes everything much more complicated – but also much safer.
Joe also highlights some recent news, including MAPS PBC rebranding to Lykos Therapeutics, symptoms from traumatic brain injuries being improved by the combination of ibogaine and magnesium, and more! Click here to head to the show notes page.